Julie Bain, PA
Physician Assistant · Oak Ridge, NCNPI 1831279561
Payments from drug & device makers
Across 101 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$279
- Boehringer Ingelheim$215
- AbbVie$128
- GSK$118
- Lilly USA, LLC$115
- Merck$105
- plus $897 from 24 others
What the payments were for
- Food & beverage$1,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $279 |
| Boehringer Ingelheim | 11 | $215 |
| AbbVie | 7 | $128 |
| GSK | 6 | $118 |
| Lilly USA, LLC | 6 | $115 |
| Merck | 6 | $105 |
| Pfizer | 5 | $101 |
| AstraZeneca | 6 | $89 |
| Astellas Pharma US Inc | 5 | $84 |
| Abbott | 4 | $82 |
| Johnson & Johnson | 4 | $65 |
| Dexcom, Inc. | 2 | $56 |
| Bayer | 2 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| Mylan Specialty L.p. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Novartis | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$1,858 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 28 | $23,456 |
| JardianceEmpagliflozin | 20 | $21,561 |
| MounjaroTirzepatide | 15 | $15,847 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $12,871 |
| MyrbetriqMirabegron | 19 | $9,216 |
| EliquisApixaban | 16 | $8,404 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 24 | $5,342 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $4,595 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,640 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 24 | $1,682 |
| Fluticasone Propionate | 87 | $1,276 |
| Rosuvastatin Calcium | 89 | $1,238 |
| Duloxetine Hcl | 58 | $1,153 |
| Atorvastatin Calcium | 146 | $896 |
| Omeprazole | 104 | $828 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $105 | $23,45628 claims |
| Boehringer IngelheimJardiance | $215 | $21,56120 claims |
| Lilly USA, LLCMounjaro | $115 | $15,84715 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $30 | $12,87113 claims |
| Astellas Pharma US IncMyrbetriq | $84 | $9,21619 claims |
| PfizerEliquis | $101 | $8,40416 claims |
| GSKShingrix | $118 | $5,34224 claims |
| AstraZenecaSymbicort | $89 | $3,64014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Oak Ridge
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.